Key result
Inflammation drives AF initiation and maintenance, linking elevated markers to longer duration and thrombogenesis.
Why the study?
Recent studies indicated inflammation may play a significant role in AF initiation, maintenance, and perpetuation, prompting an analysis of published reports on this relationship and potential therapeutic options.
Inflammation plays a significant role in the initiation and perpetuation of atrial fibrillation, suggesting that modulating the inflammatory milieu with agents like statins or ACE inhibitors may offer therapeutic benefits.
Answers are grounded in this paper and cite their sources.
Inflammation markers correlate with AF duration; leaves open whether immunomodulation improves cardioversion success or outcomes.
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Recent studies have indicated that inflammation might play a significant role in the initiation, maintenance, and perpetuation of AF. Inflammatory markers such as interleukin-6 and C-reactive protein are elevated in AF and correlate to longer duration of AF, success of cardioversion, and thrombogenesis. Furthermore, the inflammatory process might be modulated by the use of statins, angiotensin-converting enzyme inhibitors, or glucocorticoids. The purpose of this study is to analyze the current published reports on the relationship between inflammation and AF and the potential therapeutic options available to modulate the inflammatory milieu in AF.
No takes yet. Share an insight, caveat, or question.
Issac et al. (2007) conducted a review in Atrial fibrillation. Inflammation was evaluated. Inflammation plays a significant role in the initiation, maintenance, and perpetuation of atrial fibrillation, with inflammatory markers correlating to longer AF duration and thrombogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: